CYP3A4*22 GENOTYPING, EDTA BLOOD

This test detects genetic variations in the CYP3A4 gene, which influences the metabolism of various medications. It is used to personalize drug dosing and avoid adverse drug reactions, particularly for medications metabolized by this enzyme.

Also known asCyp3a4*22 Genotyping Cyp3a4*22 Genotyping

Available via

Home Collection, Lab Visit

Contains

1 parameters

Earliest reports in

8 Working Days

Test details

CYP3A4*22 GENOTYPING, EDTA BLOOD Test in Vadodara Overview

Preparations

No special preparations needed

Test included
CYP3A4*22 GENOTYPING, EDTA BLOOD includes 1 parameter

  • Cyp3a4*22 Genotyping
Frequently Asked Questions

The CYP3A4*22 Genotyping Test identifies genetic variants in the CYP3A4 gene, which affects the metabolism of various drugs, including immunosuppressants and statins.

This test helps determine an individual’s drug metabolism rate, allowing healthcare providers to personalize medication dosage and reduce adverse drug reactions.

A blood sample or buccal swab is collected and analyzed using polymerase chain reaction (PCR) to identify the CYP3A4 genetic variant.

Presence of the CYP3A422 variant may lead to slower drug metabolism, requiring dosage adjustments for optimal therapeutic effects.

Individuals with altered metabolism may need personalized medication regimens and closer monitoring to avoid adverse effects.

Test code

RD1439

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Edta Whole BloodLavender Vacutainer2 ML

Specimen stability information

Edta Whole Blood

Collection instructions

Clinical History

Specimen rejection criteria

Test run frequency

Every Day TIME - 09:30

Turn around time

8 Working Days

Performing locations

Department

  • Advanced Molecular Diagnostics R&d

CPT and Loinc codes

CYP3A4*22 GENOTYPING, EDTA BLOOD

5500